Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 29 06 2019
revised: 18 11 2019
accepted: 19 11 2019
pubmed: 4 12 2019
medline: 17 2 2021
entrez: 4 12 2019
Statut: ppublish

Résumé

The first episode of psychosis is typically preceded by a prodromal phase with subthreshold symptoms and functional decline. Improved outcome prediction in this stage is needed to allow targeted early intervention. This study assesses a combined clinical and resting-state fMRI prediction model in 137 adolescents and young adults at Clinical High Risk (CHR) for psychosis from the Shanghai At Risk for Psychosis (SHARP) program. Based on outcome at one-year follow-up, participants were separated into three outcome categories including good outcome (symptom remission, N = 71), intermediate outcome (ongoing CHR symptoms, N = 30), and poor outcome (conversion to psychosis or treatment-refractory, N = 36). Validated clinical predictors from the psychosis-risk calculator were combined with measures of resting-state functional connectivity. Using multinomial logistic regression analysis and leave-one-out cross-validation, a clinical-only prediction model did not achieve a significant level of outcome prediction (F

Identifiants

pubmed: 31791912
pii: S2213-1582(19)30455-3
doi: 10.1016/j.nicl.2019.102108
pmc: PMC7229353
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

102108

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH111448
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH093294
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH064023
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101052
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH108574
Pays : United States

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Schizophr Bull. 2014 Nov;40(6):1482-90
pubmed: 24142369
Neuroimage. 2007 Aug 1;37(1):90-101
pubmed: 17560126
Lancet Psychiatry. 2014 Dec;1(7):549-58
pubmed: 26361314
Schizophr Res. 2016 Oct;176(2-3):83-94
pubmed: 27450778
Schizophr Res. 2016 Jun;173(3):159-165
pubmed: 25819936
Hum Brain Mapp. 2017 Feb;38(2):704-714
pubmed: 27699911
Mol Psychiatry. 2020 Apr;25(4):863-872
pubmed: 30283030
Schizophr Res. 2010 Feb;116(2-3):173-83
pubmed: 19861234
J Neurosci. 2015 Jan 7;35(1):267-86
pubmed: 25568120
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9866-71
pubmed: 19478071
JAMA Psychiatry. 2019 Mar 1;76(3):339
pubmed: 30725086
Schizophr Bull. 2019 Apr 25;45(3):562-570
pubmed: 29897527
Am J Psychiatry. 2008 Feb;165(2):214-20
pubmed: 18172018
Biol Psychiatry. 2019 Mar 1;85(5):379-388
pubmed: 30612699
Brain Connect. 2018 Feb;8(1):40-48
pubmed: 29130326
Schizophr Res. 2013 Dec;151(1-3):229-37
pubmed: 24176576
Curr Opin Psychiatry. 2017 May;30(3):209-219
pubmed: 28212173
Trends Cogn Sci. 2015 Dec;19(12):744-756
pubmed: 26493362
Schizophr Res. 2004 Jun 1;68(2-3):283-97
pubmed: 15099610
Hum Brain Mapp. 2017 Apr;38(4):1741-1750
pubmed: 28009080
Schizophr Bull. 2011 May;37(3):514-23
pubmed: 21505118
Neuroimage Clin. 2012 Sep 23;1(1):91-8
pubmed: 24179741
Biol Psychiatry. 2011 May 15;69(10):959-66
pubmed: 21167475
Schizophr Bull. 2009 May;35(3):509-27
pubmed: 19155345
World Psychiatry. 2015 Oct;14(3):322-32
pubmed: 26407788
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):688-93
pubmed: 11209066
Am J Psychiatry. 2016 Oct 1;173(10):989-996
pubmed: 27363511
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Am J Psychiatry. 2008 Feb;165(2):203-13
pubmed: 18172019
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 May;1(3):199-208
pubmed: 29560880
Am J Psychiatry. 2018 Sep 1;175(9):906-908
pubmed: 30173545
Behav Brain Funct. 2010 Oct 11;6:58
pubmed: 20932348
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
Nat Commun. 2018 Sep 21;9(1):3836
pubmed: 30242220
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1279-84
pubmed: 19164577
Am J Psychiatry. 2016 Oct 1;173(10):980-988
pubmed: 27363508
Biol Psychiatry. 2019 Apr 1;85(7):573-583
pubmed: 30691673
Schizophr Bull. 2012 Nov;38(6):1268-76
pubmed: 22290265
Psychol Med. 2016 Oct;46(13):2771-83
pubmed: 27396386
PLoS One. 2013 Jun 19;8(6):e66500
pubmed: 23840493
Br J Psychiatry. 1995 May;166(5):654-9
pubmed: 7620753
Neuroimage. 2012 Mar;60(1):623-32
pubmed: 22233733
Schizophr Bull. 1996;22(2):353-70
pubmed: 8782291
Mol Psychiatry. 2015 Dec;20(12):1508-15
pubmed: 26033240
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Dialogues Clin Neurosci. 2018 Jun;20(2):101-111
pubmed: 30250387
Mol Psychiatry. 2020 Oct;25(10):2431-2440
pubmed: 30410064
Neuron. 2014 Jul 2;83(1):238-51
pubmed: 24991964
JAMA Psychiatry. 2016 Jun 1;73(6):598-605
pubmed: 27145286
Neuroimaging Clin N Am. 2017 Nov;27(4):709-723
pubmed: 28985939
Schizophr Bull. 2015 Mar;41(2):471-82
pubmed: 24914177
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
PLoS One. 2015 Aug 12;10(8):e0135347
pubmed: 26267069

Auteurs

Guusje Collin (G)

McGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: gcollin@mit.edu.

Alfonso Nieto-Castanon (A)

McGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Psychology, Northeastern University, Boston, MA, USA; Department of Speech, Language & Hearing Sciences, Boston University, Boston, MA, USA.

Martha E Shenton (ME)

Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Research and Development, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.

Ofer Pasternak (O)

Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Sinead Kelly (S)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Matcheri S Keshavan (MS)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Larry J Seidman (LJ)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Robert W McCarley (RW)

Department of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.

Margaret A Niznikiewicz (MA)

Department of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.

Huijun Li (H)

Florida A&M University, Department of Psychology, Tallahassee, FL, USA.

Tianhong Zhang (T)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yingying Tang (Y)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

William S Stone (WS)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Jijun Wang (J)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: jijunwang27@163.com.

Susan Whitfield-Gabrieli (S)

Department of Psychology, Northeastern University, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH